Cargando…
Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro
Background: Triple-negative breast cancer (TNBC) is an aggressive subtype with the most unfavorable clinical outcomes, in part due to tumor heterogeneity, treatment resistance, and tumor relapse. The TNBC subtypes [basal-like 1 (BL1), basal-like 2 (BL2), mesenchymal (M), and luminal androgen recepto...
Autores principales: | Olsson, Maxim, Larsson, Peter, Johansson, Junko, Sah, Vasu R., Parris, Toshima Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523387/ https://www.ncbi.nlm.nih.gov/pubmed/37771376 http://dx.doi.org/10.3389/fcell.2023.1237673 |
Ejemplares similares
-
Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary?
por: Hu, Ye, et al.
Publicado: (2020) -
The Iron-Inflammation Axis in Early-Stage Triple-Negative Breast Cancer
por: Duan, Fangfang, et al.
Publicado: (2022) -
Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer
por: Dong, Menglu, et al.
Publicado: (2022) -
Genome Instability-Derived Genes Are Novel Prognostic Biomarkers for Triple-Negative Breast Cancer
por: Guo, Maoni, et al.
Publicado: (2021) -
Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells
por: Rosado-Galindo, Heizel, et al.
Publicado: (2023)